Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Vor Biopharma has a consensus price target implying 124.6% upside, but the article notes that price targets are often unreliable. The more meaningful signal is an upward trend in earnings estimate revisions, which could support near-term stock upside. Overall, the piece is cautiously constructive rather than a definitive bullish catalyst.

Analysis

Vor Biopharma has a consensus price target implying 124.6% upside, but the article notes that price targets are often unreliable. The more meaningful signal is an upward trend in earnings estimate revisions, which could support near-term stock upside. Overall, the piece is cautiously constructive rather than a definitive bullish catalyst.